Figure 3. Willingness To Try Experimental Treatments and Risk Side Effects.

5-point Likert scale responses were utilized for the following questions: (A) “Assuming equal effectiveness and safety, what is your willingness to try these EXPERIMENTAL treatments for cutaneous neurofibromas?”; (B) “What side effects are you willing to risk for treatment of your cutaneous neurofibromas even if they may grow back later?”